Found 27 results
Author Title Type [ Year(Asc)]
Filters: Author is Bernstein, David I  [Clear All Filters]
L. E. Widdice, Unger, E. R., Panicker, G., Hoagland, R., S Callahan, T., Jackson, L. A., Berry, A. A., Kotloff, K., Frey, S. E., Harrison, C. J., Pahud, B. A., Edwards, K. M., Mulligan, M. J., Sudman, J., and Bernstein, D. I., Antibody responses among adolescent females receiving two or three quadrivalent human papillomavirus vaccine doses at standard and prolonged intervals., Vaccine, vol. 36, no. 6, pp. 881-889, 2018.
L. E. Widdice, Hoagland, R., S Callahan, T., Kahn, J. A., Harrison, C. J., Pahud, B. A., Frey, S. E., Berry, A. A., Kotloff, K. L., Edwards, K. M., Mulligan, M. J., Sudman, J., Nakamura, A., and Bernstein, D. I., Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination series., Vaccine, vol. 36, no. 11, pp. 1491-1499, 2018.
K. V. Houser, Yamshchikov, G. V., Bellamy, A. R., May, J., Enama, M. E., Sarwar, U., Larkin, B., Bailer, R. T., Koup, R., Paskel, M., Subbarao, K., Anderson, E., Bernstein, D. I., Creech, B., Keyserling, H., Spearman, P., Wright, P. F., Graham, B. S., and Ledgerwood, J. E., DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial., PLoS One, vol. 13, no. 11, p. e0206837, 2018.
R. C. Brady, Jackson, L. A., Frey, S. E., Shane, A. L., Walter, E. B., Swamy, G. K., Schlaudecker, E. P., Szefer, E., Wolff, M., McNeal, M. Malone, Bernstein, D. I., and Steinhoff, M. C., Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women., Vaccine, vol. 36, no. 31, pp. 4663-4671, 2018.
J. E. Ledgerwood, Bellamy, A. R., Belshe, R., Bernstein, D. I., Edupuganti, S., Patel, S. M., Renehan, P., Zajdowicz, T., Schwartz, R., Koup, R., Bailer, R. T., Yamshchikov, G. V., Enama, M. E., Sarwar, U., Larkin, B., and Graham, B. S., DNA priming for seasonal influenza vaccine: a phase 1b double-blind randomized clinical trial., PLoS One, vol. 10, no. 5, p. e0125914, 2015.
D. I. Bernstein, Atmar, R. L., G Lyon, M., Treanor, J. J., Chen, W. H., Jiang, X., Vinjé, J., Gregoricus, N., Frenck, R. W., Moe, C. L., Al-Ibrahim, M. S., Barrett, J., Ferreira, J., Estes, M. K., Graham, D. Y., Goodwin, R., Borkowski, A., Clemens, R., and Mendelman, P. M., Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults., J Infect Dis, vol. 211, no. 6, pp. 870-8, 2015.
S. E. Frey, Bernstein, D. I., Brady, R. C., Keitel, W. A., Sahly, H. El, Rouphael, N. Georges, Mulligan, M. J., Atmar, R. L., Edupuganti, S., Patel, S. M., Dickey, M., Graham, I., Anderson, E. L., Noah, D. L., Hill, H., Wolff, M., and Belshe, R. B., Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations., Vaccine, vol. 33, no. 1, pp. 163-73, 2015.
N. B. Halasa, Gerber, M. A., Berry, A. A., Anderson, E. L., Winokur, P., Keyserling, H., Eckard, A. Ross, Hill, H., Wolff, M. C., McNeal, M. M., Edwards, K. M., and Bernstein, D. I., Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age., J Pediatric Infect Dis Soc, vol. 4, no. 3, pp. 214-24, 2015.